India’s Most Trusted Cancer Treatment

Immunotherapy, widely gaining recognition as the 4th modality of cancer treatment, functions by activating the body's immune system to recognize and eliminate cancer cells. By augmenting the body's natural defenses, it offers a precise and personalized strategy for combating cancer. This innovative approach empowers the immune system, enabling it to identify and target cancer cells with greater accuracy. Immunotherapy represents a paradigm shift in cancer care, harnessing the body's inherent abilities to enhance the effectiveness of treatment while minimizing the impact on healthy tissues.

The cost of immunotherapy in Delhi, India, depends on the unique treatment plan and the type of cancer being addressed. Generally more affordable than in Western countries, it offers a cost-effective alternative for patients seeking advanced cancer treatments. To obtain accurate cost estimates, individuals are advised to consult with healthcare providers who can provide tailored information based on the specific circumstances of the patient and the treatment required. This ensures transparency and allows patients to make informed decisions regarding their healthcare options in Delhi. Typically there are various factors to consider before a patient receives immunotherapy. Some of these factors include the stage of the cancer, the histology, previous treatments availed and the overall health of a patient.

Oncologists, particularly those specializing in cancer treatment, are qualified to administer immunotherapy. These experienced oncologists at Denvax specialize in cancer treatment and are qualified to administer immunotherapy, providing expert care tailored to the specific medical requirements of their patients.

• Dr. Jamal A. Khan MBBS, MD (Medical Microbiology)
• Dr. Sharmin Yaqin MBBS, MD (Clinical Biochemistry)
• Dr. Raman Yadav MBBS, MD
• Dr. Rakesh Reddy Jillela MBBS, MD

Immunotherapy works by harnessing the body's immune system to identify and combat cancer cells. It employs various techniques, such as immune checkpoint inhibitors and monoclonal antibodies. Immune checkpoint inhibitors block proteins that inhibit the immune response, allowing immune cells to recognize and attack cancer more effectively. Monoclonal antibodies, on the other hand, target specific proteins on cancer cells, marking them for destruction by the immune system. By enhancing these natural defense mechanisms, immunotherapy offers a precise and powerful strategy, bolstering the body's ability to fight and eliminate cancer.

Here are some cancer types that are treated with immunotherapy.

• Lung Cancer: Immunotherapy has shown efficacy in treating both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
• Melanoma: Immunotherapy, particularly immune checkpoint inhibitors, has been successful in treating melanoma, a type of skin cancer.
• Breast Cancer: Certain subtypes of breast cancer, such as triple-negative breast cancer, may respond positively to immunotherapy.
• Bladder Cancer: Immunotherapy, including immune checkpoint inhibitors, is used to treat some forms of bladder cancer.
• Kidney Cancer: Immunotherapy is utilized as a treatment option for renal cell carcinoma, the most common type of kidney cancer.
• Head and Neck Cancer: Some patients with head and neck cancers, including squamous cell carcinoma, may benefit from immunotherapy.
• Colorectal Cancer: Immunotherapy is being investigated as a treatment for colorectal cancer, particularly in advanced or metastatic cases.
• Hodgkin Lymphoma: Immunotherapy, such as checkpoint inhibitors, is used in the treatment of Hodgkin lymphoma.
• Non-Hodgkin Lymphoma: Certain types of non-Hodgkin lymphomas may respond to immunotherapy, including CAR-T cell therapy.
• Liver Cancer: Immunotherapy is being explored as a treatment option for hepatocellular carcinoma, the most common type of liver cancer.

Immunotherapy's broad applicability across various cancer types underscores its potential as a promising and versatile approach to improving outcomes in cancer treatment.

In Delhi, immunotherapy provides targeted cancer treatment with fewer side effects. Benefits include improved survival rates, enhanced quality of life, and a more tailored therapeutic approach.

• Targeted Treatment: Immunotherapy in Delhi offers precision in targeting cancer cells, minimizing damage to healthy tissues.
• Fewer Side Effects: Compared to traditional treatments like chemotherapy, immunotherapy often results in fewer and less severe side effects.
• Improved Survival Rates: Many cancer patients in Delhi experience improved survival outcomes with the use of immunotherapy.
• Enhanced Quality of Life: Immunotherapy can contribute to a better quality of life for patients, as it focuses on bolstering the body's own defenses against cancer.
• Tailored Therapeutic Approach: Immunotherapy is customizable to individual patients, allowing for a more tailored and personalized treatment strategy.
• Reduced Relapse Risk: Some immunotherapies have shown effectiveness in reducing the risk of cancer recurrence.
• Effective for Various Cancers: Immunotherapy demonstrates efficacy across different types of cancers, broadening its application.
• Less Impact on Normal Cells: By harnessing the body's immune system, immunotherapy is designed to spare normal cells from extensive damage during treatment.
• Potential for Long-Term Responses: Certain patients in Delhi may experience long-lasting responses to immunotherapy, leading to sustained remission.
• Complementary to Other Treatments: Immunotherapy can be used in conjunction with other cancer treatments, providing a comprehensive and synergistic approach to combating cancer in Delhi.

In India, a diverse range of immunotherapy options is available, encompassing checkpoint inhibitors, cancer vaccines, and adoptive cell therapy. Oncologists tailor treatment plans to individual patient profiles, ensuring the administration of the most suitable and effective therapy.

• Checkpoint Inhibitors: These drugs block certain proteins on immune cells, enabling the immune system to recognize and attack cancer cells more effectively.
• Cancer Vaccines: Designed to stimulate the immune system, cancer vaccines encourage the body to recognize and target specific cancer cells.
• Adoptive Cell Therapy: This involves extracting immune cells (such as T cells) from the patient, modifying them to enhance their cancer-fighting abilities, and then reintroducing them into the patient's body.
• Monoclonal Antibodies: Engineered antibodies can target specific proteins on cancer cells, aiding the immune system in recognizing and destroying the cancer.
• Interferons and Interleukins: These signaling proteins enhance the immune system's response, activating immune cells to attack cancer cells more vigorously.
• Oncolytic Virus Therapy: Certain viruses are modified to selectively infect and kill cancer cells, while sparing normal cells. This approach can stimulate an immune response against the tumor.
• Immune System Modulators: Drugs that modulate the overall activity of the immune system, either by boosting its response or regulating specific pathways involved in immune function.
• Tumor-Infiltrating Lymphocytes (TILs): TILs are immune cells extracted from the tumor, grown in the lab, and then infused back into the patient to enhance the immune response against cancer.
• CAR-T Cell Therapy: Chimeric Antigen Receptor T-cell therapy involves genetically modifying a patient's own T cells to express a receptor that targets cancer cells, providing a highly targeted approach.
• Dendritic Cell Therapy: Dendritic cells, key regulators of the immune system, are manipulated to stimulate an immune response against cancer when reintroduced into the patient.

Immunotherapy gives hope in treating stage 4 cancers, and in some cases, it has helped patients achieve complete remission. While it's not a sure thing, it provides a helpful choice for dealing with and sometimes beating advanced cancer stages. Immunotherapy works by boosting the body's immune system to fight against cancer cells. People with stage 4 cancers, where the cancer has spread, have seen positive outcomes with this treatment. It's essential to know that everyone's response is different, and not all cases result in a cure. Still, the progress in using immunotherapy for stage 4 cancers brings optimism and a new way to approach advanced stages of the disease. Learn more about Success Rate of Immunotherapy